carbostyril has been researched along with Keratitis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boldrini, E; Campa, M; Celandroni, F; Davini, P; Ghelardi, E; Parisio, E; Salvetti, S; Senesi, S; Tavanti, A | 1 |
Erjongmanee, S; Kasetsuwan, N; Pariyakanok, L; Phusitphoykai, N; Puangsricharern, V | 1 |
Behrens-Baumann, W; Pleyer, U | 1 |
Abalain, ML; Colin, J; Jauch, A; Malet, F | 1 |
Kononenko, LA; Maĭchuk, IuF; Vakhova, ES | 1 |
Gordon, YJ; Kowalski, RP; Romanowski, EG; Yates, KA | 1 |
Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ; Reidy, JJ | 1 |
1 review(s) available for carbostyril and Keratitis
Article | Year |
---|---|
[Therapy and prognosis of bacterial keratitis].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Drug Combinations; Eye Infections, Bacterial; Humans; Keratitis; Ophthalmic Solutions; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Quinolones; Steroids; Treatment Outcome | 2007 |
2 trial(s) available for carbostyril and Keratitis
Article | Year |
---|---|
Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Cefazolin; Double-Blind Method; Female; Fluoroquinolones; Gentamicins; Humans; Keratitis; Male; Ophthalmic Solutions; Prospective Studies; Quinolones | 2004 |
[Lomefloxacin in treatment of infectious eye diseases].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Conjunctivitis, Bacterial; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Keratitis; Male; Quinolones; Steroids; Treatment Outcome; Uveitis | 1998 |
4 other study(ies) available for carbostyril and Keratitis
Article | Year |
---|---|
A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.
Topics: Adhesives; Administration, Topical; Animals; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Colony Count, Microbial; Excipients; Eye; Fluoroquinolones; Keratitis; Mucous Membrane; Ofloxacin; Plant Extracts; Pseudomonas Infections; Quinolones; Rabbits; Seeds; Staphylococcal Infections; Tamarindus | 2004 |
Bacterial keratitis therapy in guinea pigs with lomefloxacin by initially high-followed by low-dosage regimen.
Topics: Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoroquinolones; Guinea Pigs; Keratitis; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Time Factors | 1995 |
Lomefloxacin is an effective treatment of experimental bacterial keratitis.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Drug Evaluation, Preclinical; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Microbial Sensitivity Tests; Models, Animal; Ophthalmic Solutions; Quinolones; Rabbits | 2001 |
Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Topics: Animals; Ciprofloxacin; Collagen; Colony Count, Microbial; Cornea; Drug Resistance, Microbial; Eye Infections, Bacterial; Keratitis; Norfloxacin; Pharmaceutical Vehicles; Pseudomonas aeruginosa; Quinolones; Rabbits; Tobramycin | 1990 |